Literature DB >> 31023117

Evaluation of Jordanian Healthcare Providers' Knowledge, Attitudes, and Practice Patterns towards Probiotics.

Mera Ababneh1, Nour Elrashed1, Ahmad Al-Azayzih1.   

Abstract

Objectives: The current study aimed to evaluate knowledge, attitudes, and practice patterns of health-care providers (HCPs) toward probiotics.
Methods: This was a face-to-face interview in a random sample (n = 205) of physicians and clinical pharmacist in different Jordanian health-care institutions during the period of 1, June 2017-31, August 2017. A structured validated questionnaire was used to achieve study objectives.
Results: Half of HCPs (51.5%) had fair knowledge about probiotics, and pediatricians were the most knowledgeable group of HCPs. Around Fifty-nine percent of HCPs had positive attitudes toward probiotics. However, less than half of HCPs (41.0%) had ever recommended or prescribed probiotics to patients.
Conclusion: The results of this study reveal that HCPs have limited knowledge of probiotics although they have positive attitudes toward them. This is not reflected in their own clinical practice. Additional training and education about probiotics among HCPs are very imperative to enhance patient's care.

Entities:  

Keywords:  Probiotics; attitude; health-care providers; knowledge; prescribing

Mesh:

Year:  2019        PMID: 31023117     DOI: 10.1080/14737167.2019.1609354

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  2 in total

1.  Physicians' Understanding of the Role of the Microbiome in Allergies and Asthma: A Questionnaire-Based Study in Saudi Arabia.

Authors:  Suzan AlKhater
Journal:  J Asthma Allergy       Date:  2022-08-16

2.  Evaluating Knowledge of Human Microbiota among University Students in Jordan, an Online Cross-Sectional Survey.

Authors:  Anas H A Abu-Humaidan; Jawad A Alrawabdeh; Laith S Theeb; Yazan I Hamadneh; Mohammad B Omari
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.